South Dakota medical cannabis home cultivation has increased more than 1,000 percent in four years, rising from 61 authorized patients to 715. The surge highlights growing pressure around affordability, patient access, dispensary strategy, cultivation oversight, and the balance between personal cultivation and the regulated commercial market.

Rhode Island cannabis retail licensing is moving again after a federal judge lifted an injunction that had frozen the state's application and selection process. Applicants now face a revised system with new deadlines, updated ownership rules, site control requirements, and renewed pressure around capital and market entry.

A Yale Budget Lab analysis estimates federal cannabis legalization could produce $57.9 billion in federal excise tax revenue over ten years, rising to $111.3 billion if every remaining state also legalizes. The bigger operator question is how legalization would reshape taxation, 280E, banking, interstate commerce, illicit market competition, and the economics of the regulated industry.

Georgia is considering allowing licensed dispensaries to mail medical cannabis directly to registered patients within the state following new federal Schedule III treatment. The proposal could expand patient access dramatically, but operators still need clarity around DEA requirements, postal rules, carrier acceptance, tracking, security, and patient verification.

Cannabis operators are increasingly treating customer and patient data as a competitive asset that can guide product decisions, marketing, inventory, and expansion. In mature markets, the businesses that understand acquisition cost, customer behavior, product performance, and margins may have a stronger advantage than those focused on growth without measurement.

Illinois adult use dispensaries will be able to opt into medical cannabis licensing beginning September 10, opening new opportunities around patient access, retail sales, DEA registration, and federal tax planning. The bigger lesson is that cannabis license structure is becoming increasingly important as state medical programs interact with new federal Schedule III rules.